For the first time in nearly two decades, the number of Americans dying from drug overdoses declined year over year. The Centers for Disease Control and Prevention reported that roughly 68,500 people died of a drug overdose in 2018, down from about 72,000 in 2017 — a 5% decrease and the first annual drop since 1999.
At a glance
- Overdose deaths: About 68,500 Americans died of drug overdoses in 2018, compared with roughly 72,000 the year before, according to provisional CDC data.
- Substance use disorder: The number of American adults battling a substance use disorder also fell — from an estimated 20.1 million in 2016 to 19.7 million in 2017, per the National Survey on Drug Use and Health.
- Drug epidemic trend: The 2018 figures mark the first year-over-year decline in overdose deaths since 1999, when the CDC began tracking the current stretch of rising drug mortality.
Why the drop matters
The opioid crisis reshaped American life over two decades. Overdose deaths climbed almost every year from 1999 onward, touching every state, gutting rural communities, and overwhelming emergency rooms. A reversal — even a modest one — signals that the collective response is starting to work.
That response has involved many moving parts: expanded access to naloxone, wider adoption of medication-assisted treatment like buprenorphine, stricter prescribing guidelines for opioids, and sustained community-level outreach. No single intervention explains the drop, but together they appear to have bent the curve.
Stories like this one are part of a broader set of public health wins that rarely receive the same attention as the crises that precede them.
What the CDC data shows — and what it doesn’t
The 5% decline is real, but the picture inside the data is mixed. While deaths involving opioids fell overall, the CDC figures show that deaths involving cocaine and psychostimulants — including methamphetamine and MDMA — actually rose from 2017 to 2018. The epidemic did not end; it shifted.
Anna Lembke, a professor of psychiatry and behavioral sciences at Stanford University and author of Drug Dealer, MD, called the decrease “encouraging” but cautioned against treating it as cause for celebration. She noted that overdose deaths are only one way to measure an epidemic, and that the number of people actively battling addiction is an equally important metric — one the CDC mortality data does not capture.
A hard-won but incomplete turn
The decline in substance use disorder rates, tracked separately by the National Survey on Drug Use and Health, adds weight to the CDC finding. Taken together, both measures suggest the epidemic’s grip loosened somewhat between 2016 and 2018 — a meaningful shift after years of worsening numbers.
Still, nearly 68,500 deaths in a single year is a staggering toll. Public health experts and clinicians have been clear: a one-year dip does not mean the crisis is over. Fentanyl and other synthetic opioids remain widely available, and the stimulant drug deaths rising in parallel represent a second wave that existing interventions are less equipped to address.
What the 2018 data offers is evidence that coordinated public health efforts can move large numbers — and that the goal of reducing drug mortality is achievable. The CDC’s ongoing overdose surveillance and the work of researchers at institutions like Stanford’s Department of Psychiatry will be essential to understanding whether this reversal holds and where the next interventions are most needed.
The National Institute on Drug Abuse has long emphasized that addiction is a treatable condition. The 2018 figures are a reminder that treatment, when it reaches people in time, saves lives — and that scaling it up further remains the central challenge. For a look at how newer prevention tools are expanding access, the U.S. Department of Health and Human Services opioid response tracks federal efforts across all 50 states.
Read more
For more on this story, see: Reuters
For more from Good News for Humankind, see:
- Zimbabwe approves long-acting HIV prevention drug
- University of East Anglia researchers advance primary bone cancer treatment
- The Good News for Humankind archive on global health
About this article
- 🤖 This article is AI-generated, based on a framework created by Peter Schulte.
- 🌍 It aims to be inspirational but clear-eyed, accurate, and evidence-based, and grounded in care for the Earth, peace and belonging for all, and human evolution.
- 💬 Leave your notes and suggestions in the comments below — I will do my best to review and implement where appropriate.
- ✉️ One verified piece of good news, one insight from Antihero Project, every weekday morning. Subscribe free.
